Document is current
Any future updates will be listed below
-
Authors
Bruce, Iain A.
Ezgü, Fatih S.
Kampmann, Christoph
Kenis, Vladimir
Mackenzie, William
Stevens, Bob
Walker, Robert
Hendriksz, Christian https://orcid.org/0000-0003-2179-3639
-
Funding
Funding for this research was provided by:
biomarin pharmaceutical
- License Information
-
More Information
Article History
Received: 10 August 2021
Accepted: 6 February 2022
First Online: 2 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: FSE has received consultancy and speaker fees from BioMarin, Takeda, and Sanofi Genzyme paid to their institution, travel grants from Pfizer and Sanofi Genzyme, and has participated as an investigator for clinical trials sponsored by Sobi and Sanofi Genzyme. WM has received speaker fees from BioMarin and Web MD Medscape paid to their institutional honorarium, received a Biobank research grant from BioMarin paid to their institution, and has acted as a non-paid consultant to Little People of America and the MPS Society on medical advisory boards. BS has received grants paid to the MPS Society from Takeda, BioMarin, and Regenxbio for speaker fees and payments. CH was employed by and owned shares in FYMCA Medical Ltd. until October 2020.
